24 ноября 2017
International Advisory Council online-meeting

Prof. Andrey S. Chagin, head of the Laboratory of Regeneration of Skeletal Tissues, also made a report on Laboratory's achievements. TheLaboratory's  scientists have already prepared 6 publications. Today the most important project of the Laboratory deals with research on human articular cartilage.  Sechenov University held International Advisory Council (IAC) skype-conference on November 16, 2017. The heads of the scientific&educational departments, laboratories and centers of the University participated in the IAC online-meeting. Prof. Andrey A. Svistunov, first vice-rector of the University, presented an updated version of the Sechenov University's Academic Excellence Road Map for 2018-2020 years. The new paradigm is based on continuous system of the personalized healthcare management and is linked with the principles of Preventive and Digital Medicine, its usage in diagnostics and treatment techniques. IAC members made an assesment of the development paradigm chosen by the University, gave recommendatons for its further implementation.
Heads of the international laboratories, which were established at Sechenov University under the decision of IAC in 2016/2017 years, made evaluation reports. 
Particularly, Prof. Klaus-Peter Lesch, head of the Laboratory of Psychiatric Neurobiology accounted for anual work results.The Laboratory actively cooperates with foreign and Russian universities. According to the report, 4 doctoral dissertations were successfully prepared, 14 lectures of the famous scientists were held, 15 scientific articles were published (6 of them with the participation of graduates and students). During the meeting participants were actively involved into discussion, they exchanged opinions and gave recommendations. The next IAC onsite meeting is going to be held in May/June, 2018. Meeting agenda will contain the discussion of the possibility of international scientific collaborations and academic visibility of Sechenov University. 


про COVID-19